Abiopharma

News list

Director McKhann Chas 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000038

Full text

News bot June 22, 2026, 5:12 p.m.
🔍 McKhann Chas (Director)

Company: EXAGEN INC. (XGN)

Report Date: 2026-06-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 37,500
Detailed Transactions and Holdings:
- Acquired 37,500 shares of Stock Option(right to buy) at $4.31 per share (Derivative)
  Date: 2026-06-09 | Code: A | Expires: 2036-06-08 | Exercise: 2026-06-09 | equity_swap_involved: 0 | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.